Ascentage Pharma (AAPG) details J.P. Morgan Healthcare Conference plans

Rhea-AI Filing Summary

Ascentage Pharma Group International submitted a Form 6-K stating that on December 17, 2025 it issued a press release titled “Ascentage Pharma to Present at 44th Annual J.P. Morgan Healthcare Conference.” The report’s primary purpose is to furnish this press release as Exhibit 99.1 for U.S. investors.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of December 2025

Commission File Number: 001-42484

ASCENTAGE PHARMA GROUP INTERNATIONAL

(Translation of Registrant’s name into English)

68 Xinqing Road

Suzhou Industrial Park

Suzhou, Jiangsu

China

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐

EXPLANATORY NOTE

On December 17, 2025, Ascentage Pharma Group International issued a press releases entitled “Ascentage Pharma to Present at 44th Annual J.P. Morgan Healthcare Conference”. A copy of the press release is furnished as Exhibit 99.1.

1

INDEX TO EXHIBITS

Exhibit
Number		Exhibit Title
99.1		Press Release dated December 17, 2025

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ASCENTAGE PHARMA GROUP INTERNATIONAL
Date: December 17, 2025	/s/ Dajun Yang
	Name:	Dajun Yang
	Title:	Chief Executive Officer

3

FAQ

What did Ascentage Pharma Group International (AAPG) report in this Form 6-K?

Ascentage Pharma Group International reported that it issued a press release titled “Ascentage Pharma to Present at 44th Annual J.P. Morgan Healthcare Conference” and furnished it as an exhibit.

When did Ascentage Pharma Group International (AAPG) issue the related press release?

The company states that it issued the press release on December 17, 2025.

What event will Ascentage Pharma Group International (AAPG) present at?

The press release is titled “Ascentage Pharma to Present at 44th Annual J.P. Morgan Healthcare Conference,” indicating the company’s planned presentation at that conference.

What is Exhibit 99.1 in Ascentage Pharma Group International (AAPG)'s Form 6-K?

Exhibit 99.1 is identified as the press release dated December 17, 2025 related to the company’s presentation at the 44th Annual J.P. Morgan Healthcare Conference.

Why did Ascentage Pharma Group International (AAPG) furnish this press release to the SEC?

The company furnished the press release as an exhibit to inform U.S. investors, using the Form 6-K to formally submit Exhibit 99.1 under the Securities Exchange Act of 1934.